Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anthony Chase Insider Profile
4 Followers
Anthony Chase, Director at Sarepta Therapeutics, holds 67.19K shares in Sarepta Therapeutics (Ticker: SRPT), holds 0.00 shares in Humanigen (Ticker: HGENQ), holds 8.80K shares in LyondellBasell (Ticker: LYB).
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+18.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Anthony Chase holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 13, 2014 - Aug 13, 2015
Return:+57.30%
The most profitable trade made by Anthony Chase
Anthony Chase's Trading History
Sarepta Therapeutics
Mar 03, 2015
Director
Uninformative Buy
―
$7.99M
Humanigen
―
―
―
$0.00
Nabors Industries
Jun 05, 2024
Director
Uninformative Buy
―
$419.78K
Cullen/Frost Bankers
Jul 28, 2023
Director
Informative Buy
109.00
$132.87
Heritage-Crystal Clean
May 05, 2021
―
Uninformative Buy
47.51K
$74.68K
LyondellBasell
Oct 02, 2024
Director
Uninformative Buy
―
$646.80K
Par Pacific Holdings
Oct 10, 2023
Director
Uninformative Buy
―
$158.88K
Anadarko Petroleum
Aug 09, 2019
―
Uninformative Sell
―
$0.00
Western Gas
Dec 04, 2013
―
Informative Buy
74.98K
$426.14K
List of latest transactions for each holding click on a transaction to see Anthony Chase's performance on stock
You May Also Like
Anthony Chase insider profile FAQ
What is the percentage of profitable transactions made by Anthony Chase?
The percentage of profitable transactions made by Anthony Chase is 75%.
What is the average return per transaction made by Anthony Chase?
The average return per transaction made by Anthony Chase is 18.40%.
What stocks does Anthony Chase hold?
Anthony Chase holds: SRPT, HGENQ, NBR, CFR, HCCI, LYB, PARR, APC, ~WES stocks.
What was Anthony Chase’s latest transaction?
Anthony Chase latest transaction was an Uninformative Buy of ―.
What was Anthony Chase's most profitable transaction?
Anthony Chase’s most profitable transaction was an Informative Buy of SRPT stock on August 13, 2014. The return on the trade was 57.30%.
What is Anthony Chase's role in Sarepta Therapeutics?
Anthony Chase's role in Sarepta Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.